+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biliary Tract Cancers Market - Global Forecast 2025-2030- Product Image
Biliary Tract Cancers Market - Global Forecast 2025-2030- Product Image
Sale

Biliary Tract Cancers Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6055398
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The biliary tract cancers market is transforming as advances in diagnostics, precision medicine, and collaborative research drive progress for healthcare leaders. Senior executives, R&D strategists, and policy makers need a panoramic view of market dynamics to inform critical investments and operational planning in this complex therapeutic area.

Market Snapshot: Biliary Tract Cancers Market Size & Growth Potential

The Biliary Tract Cancers Market grew from USD 3.58 billion in 2024 to USD 3.86 billion in 2025. It is expected to continue growing at a CAGR of 8.09%, reaching USD 5.71 billion by 2030. Increasing focus on early detection, precision therapies, and global collaboration among academic and commercial entities is driving market expansion across key regions. This report consolidates the most up-to-date trends and competitive strategies, offering decision-makers an authoritative resource for long-term market planning.

Scope & Segmentation

This report comprehensively examines the multiple dimensions shaping the biliary tract cancers market, enabling leaders to benchmark performance and anticipate shifts across segments and regions.

  • Cancer Types: Cholangiocarcinoma; Gallbladder Cancer
  • Treatment Approaches: Chemotherapy; Immunotherapy; Radiation Therapy; Surgery; Targeted Therapy
  • End-User Landscape: Academic Institutions; Cancer Research Institutes; Hospitals & Clinics
  • Distribution Channels: Offline; Online
  • Geographic Coverage: Americas (with detailed country analysis for United States, Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (including UK, Germany, France, UAE, Saudi Arabia, South Africa, and more); Asia-Pacific (such as China, India, Japan, Australia, South Korea, and others)
  • Industry Leaders Analyzed: Key companies include Agios Pharmaceuticals Inc., Amgen Inc., AstraZeneca PLC, Basilea Pharmaceutica AG, BeiGene Ltd., Bristol-Myers Squibb Company, Delcath Systems Inc., Eisai Co. Ltd., Eli Lilly and Company, Exelixis Inc., F. Hoffmann-La Roche Ltd, Incyte Corporation, LES LABORATOIRES SERVIER, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A., TAIHO PHARMACEUTICAL CO. LTD., TransThera Sciences (Nanjing), Inc., Zymeworks Inc.

Key Takeaways for Senior Decision-Makers

  • New molecular diagnostics and targeted drug regimens are reshaping standards of care, enabling increasingly personalized treatment strategies for complex biliary tract malignancies.
  • Artificial intelligence and emerging digital health tools are enhancing diagnostic accuracy in both high-volume research centers and community healthcare settings.
  • Strategic partnerships among pharmaceutical leaders, biotech innovators, and academic centers are accelerating clinical validation and market entry of novel agents.
  • Supply chain resilience is critical as organizations recalibrate sourcing strategies to minimize risks associated with changing trade environments.
  • Regional distinctions in research capacity and healthcare infrastructure require adaptable approaches to maximize therapy availability and optimize real-world outcomes for diverse patient populations.

Tariff Impact on Biliary Tract Cancer Therapies

The 2025 tariff policy revisions in the United States have raised the cost of importing oncology therapeutics, diagnostics, and critical raw materials, compelling manufacturers to review production schedules and diversify supplier networks. Heightened regulatory scrutiny has driven greater emphasis on compliance, prompting some organizations to seek local manufacturing partnerships and advocate for policies that ensure steady patient access.

Methodology & Data Sources

A robust, multi-phased methodology underpins this report, integrating systematic secondary research with focused primary interviews. Peer-reviewed publications, patent databases, and registries formed the evidence base, while expert consultations provided real-world context. Thorough triangulation validates the insights, and analytical frameworks deliver actionable recommendations for both commercial and research stakeholders.

Why This Report Matters

  • Enables executives to craft informed clinical development and investment strategies backed by the latest scientific, clinical, and regulatory trends in biliary tract cancers.
  • Highlights the influence of evolving global and regional dynamics on opportunities, supply chain management, and commercial success within this high-need oncology segment.
  • Equips leaders with data to strengthen competitive positioning through partnership, risk management, and regulatory alignment.

Conclusion

Integrating multidimensional research from clinical practice, industry developments, and policy shifts, this report guides strategic choices for effective biliary tract cancer care. Empowered with forward-looking insights, decision-makers can navigate emerging challenges and drive meaningful patient outcomes in a rapidly evolving global landscape.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of FGFR2 inhibitors like pemigatinib and infigratinib for targeted treatment of FGFR2 fusion cholangiocarcinoma
5.2. Advancements in immunotherapy combinations pairing PD-1 inhibitors with chemotherapy in advanced biliary tract cancer
5.3. Growth of liquid biopsy utilization for early detection and molecular monitoring of biliary tract tumors in clinical practice
5.4. Emergence of precision oncology diagnostics to identify IDH1 mutations and guide targeted IDH1 inhibitor therapy in cholangiocarcinoma
5.5. Rising investment in antibody-drug conjugates targeting HER2 overexpression in gallbladder and extrahepatic bile duct carcinomas
5.6. Clinical integration of endoscopic radiofrequency ablation adjunctive to stenting for palliation in unresectable biliary strictures
5.7. Development of novel radiotracer imaging techniques to enhance staging accuracy and therapeutic planning in biliary tract cancers
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biliary Tract Cancers Market, by Cancer Type
8.1. Introduction
8.2. Cholangiocarcinoma
8.3. Gallbladder Cancer
9. Biliary Tract Cancers Market, by Treatment Type
9.1. Introduction
9.2. Chemotherapy
9.3. Immunotherapy
9.4. Radiation Therapy
9.5. Surgery
9.6. Targeted Therapy
10. Biliary Tract Cancers Market, by End-User
10.1. Introduction
10.2. Academic Institutions
10.3. Cancer Research Institutes
10.4. Hospitals & Clinics
11. Biliary Tract Cancers Market, by Distribution Channel
11.1. Introduction
11.2. Offline
11.3. Online
12. Americas Biliary Tract Cancers Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Biliary Tract Cancers Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Biliary Tract Cancers Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Agios Pharmaceuticals, Inc.
15.3.2. Amgen Inc.
15.3.3. AstraZeneca PLC
15.3.4. Basilea Pharmaceutica AG
15.3.5. BeiGene, Ltd.
15.3.6. Bristol-Myers Squibb Company
15.3.7. Delcath Systems, Inc.
15.3.8. Eisai Co., Ltd.
15.3.9. Eli Lilly and Company
15.3.10. Exelixis, Inc.
15.3.11. F. Hoffmann-La Roche Ltd
15.3.12. Incyte Corporation
15.3.13. LES LABORATOIRES SERVIER
15.3.14. Merck & Co., Inc.
15.3.15. Novartis AG
15.3.16. Pfizer Inc.
15.3.17. Sanofi S.A.
15.3.18. TAIHO PHARMACEUTICAL CO., LTD.
15.3.19. TransThera Sciences (Nanjing), Inc.
15.3.20. Zymeworks Inc.
16. ResearchAI17. ResearchStatistics18. ResearchContacts19. ResearchArticles20. Appendix
List of Figures
FIGURE 1. BILIARY TRACT CANCERS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BILIARY TRACT CANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BILIARY TRACT CANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BILIARY TRACT CANCERS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BILIARY TRACT CANCERS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BILIARY TRACT CANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BILIARY TRACT CANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BILIARY TRACT CANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BILIARY TRACT CANCERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BILIARY TRACT CANCERS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BILIARY TRACT CANCERS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. BILIARY TRACT CANCERS MARKET: RESEARCHAI
FIGURE 24. BILIARY TRACT CANCERS MARKET: RESEARCHSTATISTICS
FIGURE 25. BILIARY TRACT CANCERS MARKET: RESEARCHCONTACTS
FIGURE 26. BILIARY TRACT CANCERS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BILIARY TRACT CANCERS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY CHOLANGIOCARCINOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY CHOLANGIOCARCINOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY GALLBLADDER CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY GALLBLADDER CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY CANCER RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY CANCER RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BILIARY TRACT CANCERS MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. AMERICAS BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 42. AMERICAS BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 43. AMERICAS BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 44. AMERICAS BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 45. AMERICAS BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 46. AMERICAS BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS BILIARY TRACT CANCERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS BILIARY TRACT CANCERS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 51. UNITED STATES BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 52. UNITED STATES BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 53. UNITED STATES BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 54. UNITED STATES BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 55. UNITED STATES BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 56. UNITED STATES BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 57. UNITED STATES BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 58. UNITED STATES BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 59. UNITED STATES BILIARY TRACT CANCERS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 60. UNITED STATES BILIARY TRACT CANCERS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 61. CANADA BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 62. CANADA BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 63. CANADA BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 64. CANADA BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 65. CANADA BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 66. CANADA BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 67. CANADA BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 68. CANADA BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 69. MEXICO BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 70. MEXICO BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 71. MEXICO BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 72. MEXICO BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 73. MEXICO BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 74. MEXICO BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 75. MEXICO BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 76. MEXICO BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 77. BRAZIL BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 78. BRAZIL BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 79. BRAZIL BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 80. BRAZIL BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 81. BRAZIL BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 82. BRAZIL BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 83. BRAZIL BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. BRAZIL BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. ARGENTINA BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 86. ARGENTINA BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 87. ARGENTINA BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 88. ARGENTINA BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 89. ARGENTINA BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 90. ARGENTINA BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 91. ARGENTINA BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 92. ARGENTINA BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA BILIARY TRACT CANCERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA BILIARY TRACT CANCERS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 104. UNITED KINGDOM BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 106. UNITED KINGDOM BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 108. UNITED KINGDOM BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. UNITED KINGDOM BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. GERMANY BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 112. GERMANY BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 113. GERMANY BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 114. GERMANY BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 115. GERMANY BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 116. GERMANY BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 117. GERMANY BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. GERMANY BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. FRANCE BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 120. FRANCE BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 121. FRANCE BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 122. FRANCE BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 123. FRANCE BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 124. FRANCE BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 125. FRANCE BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. FRANCE BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. RUSSIA BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 128. RUSSIA BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 129. RUSSIA BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 130. RUSSIA BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 131. RUSSIA BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 132. RUSSIA BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 133. RUSSIA BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. RUSSIA BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. ITALY BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 136. ITALY BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 137. ITALY BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 138. ITALY BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 139. ITALY BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 140. ITALY BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 141. ITALY BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 142. ITALY BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 143. SPAIN BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 144. SPAIN BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 145. SPAIN BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 146. SPAIN BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 147. SPAIN BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 148. SPAIN BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 149. SPAIN BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. SPAIN BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 154. UNITED ARAB EMIRATES BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 155. UNITED ARAB EMIRATES BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 156. UNITED ARAB EMIRATES BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 157. UNITED ARAB EMIRATES BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. UNITED ARAB EMIRATES BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 160. SAUDI ARABIA BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 162. SAUDI ARABIA BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 164. SAUDI ARABIA BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. SAUDI ARABIA BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 168. SOUTH AFRICA BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 170. SOUTH AFRICA BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 172. SOUTH AFRICA BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 173. SOUTH AFRICA BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. SOUTH AFRICA BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. DENMARK BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 176. DENMARK BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 177. DENMARK BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 178. DENMARK BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 179. DENMARK BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 180. DENMARK BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 181. DENMARK BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. DENMARK BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. NETHERLANDS BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 184. NETHERLANDS BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 185. NETHERLANDS BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 186. NETHERLANDS BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 187. NETHERLANDS BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 188. NETHERLANDS BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 189. NETHERLANDS BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. NETHERLANDS BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. QATAR BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 192. QATAR BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 193. QATAR BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 194. QATAR BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 195. QATAR BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 196. QATAR BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 197. QATAR BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. QATAR BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. FINLAND BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 200. FINLAND BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 201. FINLAND BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 202. FINLAND BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 203. FINLAND BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 204. FINLAND BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 205. FINLAND BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. FINLAND BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. SWEDEN BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 208. SWEDEN BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 209. SWEDEN BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 210. SWEDEN BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 211. SWEDEN BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 212. SWEDEN BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 213. SWEDEN BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. SWEDEN BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. NIGERIA BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 216. NIGERIA BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 217. NIGERIA BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 218. NIGERIA BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 219. NIGERIA BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 220. NIGERIA BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 221. NIGERIA BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. NIGERIA BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. EGYPT BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 224. EGYPT BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 225. EGYPT BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 226. EGYPT BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 227. EGYPT BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 228. EGYPT BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 229. EGYPT BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. EGYPT BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. TURKEY BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 232. TURKEY BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 233. TURKEY BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 234. TURKEY BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 235. TURKEY BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 236. TURKEY BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 237. TURKEY BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. TURKEY BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. ISRAEL BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 240. ISRAEL BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 241. ISRAEL BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 242. ISRAEL BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 243. ISRAEL BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 244. ISRAEL BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 245. ISRAEL BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. ISRAEL BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. NORWAY BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 248. NORWAY BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 249. NORWAY BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 250. NORWAY BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 251. NORWAY BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 252. NORWAY BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 253. NORWAY BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. NORWAY BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. POLAND BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 256. POLAND BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 257. POLAND BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 258. POLAND BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 259. POLAND BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 260. POLAND BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 261. POLAND BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. POLAND BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. SWITZERLAND BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 264. SWITZERLAND BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 265. SWITZERLAND BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 266. SWITZERLAND BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 267. SWITZERLAND BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 268. SWITZERLAND BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 269. SWITZERLAND BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. SWITZERLAND BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 272. ASIA-PACIFIC BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 274. ASIA-PACIFIC BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 276. ASIA-PACIFIC BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. ASIA-PACIFIC BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. ASIA-PACIFIC BILIARY TRACT CANCERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 280. ASIA-PACIFIC BILIARY TRACT CANCERS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 281. CHINA BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 282. CHINA BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 283. CHINA BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 284. CHINA BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 285. CHINA BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 286. CHINA BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 287. CHINA BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. CHINA BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. INDIA BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 290. INDIA BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 291. INDIA BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 292. INDIA BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 293. INDIA BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 294. INDIA BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 295. INDIA BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. INDIA BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. JAPAN BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 298. JAPAN BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 299. JAPAN BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 300. JAPAN BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 301. JAPAN BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 302. JAPAN BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 303. JAPAN BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. JAPAN BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 305. AUSTRALIA BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 306. AUSTRALIA BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 307. AUSTRALIA BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 308. AUSTRALIA BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 309. AUSTRALIA BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 310. AUSTRALIA BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 311. AUSTRALIA BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. AUSTRALIA BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. SOUTH KOREA BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 314. SOUTH KOREA BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 315. SOUTH KOREA BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 316. SOUTH KOREA BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 317. SOUTH KOREA BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 318. SOUTH KOREA BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 319. SOUTH KOREA BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 320. SOUTH KOREA BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 321. INDONESIA BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 322. INDONESIA BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 323. INDONESIA BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 324. INDONESIA BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 325. INDONESIA BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 326. INDONESIA BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 327. INDONESIA BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 328. INDONESIA BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 329. THAILAND BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 330. THAILAND BILIARY TRACT CANCERS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 331. THAILAND BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 332. THAILAND BILIARY TRACT CANCERS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 333. THAILAND BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 334. THAILAND BILIARY TRACT CANCERS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 335. THAILAND BILIARY TRACT CANCERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 336. THAILAND BILIARY

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Biliary Tract Cancers market report include:
  • Agios Pharmaceuticals, Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Basilea Pharmaceutica AG
  • BeiGene, Ltd.
  • Bristol-Myers Squibb Company
  • Delcath Systems, Inc.
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • Exelixis, Inc.
  • F. Hoffmann-La Roche Ltd
  • Incyte Corporation
  • LES LABORATOIRES SERVIER
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • TAIHO PHARMACEUTICAL CO., LTD.
  • TransThera Sciences (Nanjing), Inc.
  • Zymeworks Inc.

Table Information

Report AttributeDetails
No. of Pages182
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.86 billion
Forecasted Market Value ( USD ) by 2030 $ 5.71 billion
Compound Annual Growth Rate8.0%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Biliary Tract Cancers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Biliary Tract Cancers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Biliary Tract Cancers - Global Strategic Business Report - Product Image

Biliary Tract Cancers - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Biliary Tract Cancer Global Market Report 2025 - Product Image

Biliary Tract Cancer Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Biliary Tract Cancer (BTC)- Pipeline Insight, 2025 - Product Image

Biliary Tract Cancer (BTC)- Pipeline Insight, 2025

  • Clinical Trials
  • 180 Pages
  • Global
From
Biliary Tract Cancers Pipeline Analysis Report 2025 - Product Image

Biliary Tract Cancers Pipeline Analysis Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.